Derivation and validation of a risk classification tree for patients with synovial sarcoma

by Dylan V. Neel, Clement Ma, Natalie B. Collins, Jason L. Hornick, George D. Demetri, David S. Shulman
Published 2023-01-01

Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center

by Ajami Gikandi, Susan N. Chi, Kee Kiat Yeo, Allison F. O'Neill, David S. Shulman, Steven G. DuBois, Natalie B. Collins
Published 2024-04-01

PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment

by Yashaswi Shrestha, Michael Quigley, Travis Hughes, Robert T Manguso, Natalie B Collins, Rose Al Abosy, Brian C Miller, Kevin Bi, Qihong Zhao, Jeffrey J Ishizuka, Kathleen B Yates, Hans W Pope, Marc Wadsworth, Alex K Shalek, Jesse S Boehm, William C Hahn, John G Doench, W Nicholas Haining
Published 2022-03-01